Abstract
Hepatitis-associated aplastic anemia (HAAA), a rare subtype of aplastic anemia (AA), is defined as bone marrow failure occurring after acute hepatitis. Severe HAAA requires immunosuppressive therapy (IST) or hematopoietic stem cell transplantation (HSCT) as lifesaving treatment. The outcomes of HAAA patients who underwent haploidentical hematopoietic stem cell transplantation (haplo-HSCT) have not been systematically evaluated. We retrospectively compared the characteristics of 15 patients with HAAA and 60 non-hepatitis-associated aplastic anemia (non-HAAA) patients, all 75 of whom underwent haplo-HSCT in our hospital between January 2006 and October 2021. The median ages of the patients were 18 years old (range, 3–36) for HAAA patients and 13 years (range, 2–45) for non-HAAA patients (p = 0.693). The median time for neutrophil engraftment was 14 days (range, 11–22) in the HAAA group and 12 days (range, 10–21) in the non-HAAA group (p = 0.363). At the time of analysis, 15 HAAA patients and 58 non-HAAA patients were alive, and their median follow-up times were 37 (range, 3–87) months and 31 (range, 2–110) months (p = 0.347), respectively. There were no significant differences in the three-year overall survival (OS) rates (100% vs. 96.7 ± 0.33%, P = 0.638) or liver event-free survival (LEFS) (80.0 ± 0.17% vs. 76.7 ± 0.19%, P = 0.747) between the two groups. Despite the small number of HAAA patients due to the rarity of the disease, these results, such as the similar incidence rates of 3-year OS and fewer liver events than expected, suggest that haplo-HSCT is a feasible treatment for HAAA a when there are no human leukocyte antigen (HLA)-matched donors available and has a low risk of transplant-related mortality and complications.
Similar content being viewed by others
Data availability
The original contributions presented in the study are included in the article, and further inquiries can be directed to the corresponding author/s.
References
Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS (1997) Hepatitis-associated aplastic anemia. N Engl J Med 336(15):1059–1064. https://doi.org/10.1056/nejm199704103361504
Rauff B, Idrees M, Shah SAR, Butt S, Butt AM, Ali L, Hussain A, Irshad Ur R, Ali M (2011) Hepatitis associated aplastic anemia: a review. Virol J 8:87. https://doi.org/10.1186/1743-422X-8-87
Alshaibani A, Dufour C, Risitano A, de Latour R, Aljurf M (2020) Hepatitis-associated aplastic anemia. Hematol Oncol Stem Cell Ther. https://doi.org/10.1016/j.hemonc.2020.10.001
Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R (2009) Systematic review: hepatitis-associated aplastic anaemia–a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther 30(5):436–443. https://doi.org/10.1111/j.1365-2036.2009.04060.x
Mary JY, Baumelou E, Guiguet M (1990) Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 75(8):1646–1653
Locasciulli A, Bacigalupo A, Bruno B, Montante B, Marsh J, Tichelli A, Socié G, Passweg J (2010) Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party. Br J Haematol 149(6):890–895. https://doi.org/10.1111/j.1365-2141.2010.08194.x
Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS (1992) Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA 267(15):2051–2054
Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JCW (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187–207. https://doi.org/10.1111/bjh.13853
Xu L-P, Wang S-Q, Wu D-P, Wang J-M, Gao S-J, Jiang M, Wang C-B, Zhang X, Liu Q-F, Xia L-H, Wang X, Huang X-J (2016) Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol 175(2):265–274. https://doi.org/10.1111/bjh.14225
Xu L-P, Jin S, Wang S-Q, Xia L-H, Bai H, Gao S-J, Liu Q-F, Wang J-M, Wang X, Jiang M, Zhang X, Wu D-P, Huang X-J (2017) Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10(1):25. https://doi.org/10.1186/s13045-017-0398-y
Zhu H, Luo RM, Luan Z, Lee V, Zhu YP, Luo CJ, Tang XF, Si YJ, Chen J (2016) Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia. Br J Haematol 174(5):799–805. https://doi.org/10.1111/bjh.14110
Lu Y, Sun R-J, Zhao Y-L, Xiong M, Cao X-Y, Zhang J-P, Wei Z-J, Zhou J-R, Liu D-Y, Lu D-P (2018) Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia. Biol Blood Marrow Transplant 24(9):1881–1887. https://doi.org/10.1016/j.bbmt.2018.05.015
Zeng Y, Wang S, Wang J, Liu L, Su Y, Lu Z, Zhang X, Zhang Y, Zhong JF, Peng L, Liu Q, Lu Y, Gao L, Zhang X (2018) Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: a large-sample study from China. Sci Rep 8(1):2479. https://doi.org/10.1038/s41598-018-20853-9
Zhang X-H, Chen J, Han M-Z, Huang H, Jiang E-L, Jiang M, Lai Y-R, Liu D-H, Liu Q-F, Liu T, Ren H-Y, Song Y-P, Sun Z-M, Tang X-W, Wang J-M, Wu D-P, Xu L-P, Zhang X, Zhou D-B, Huang X-J (2021) The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14(1):145. https://doi.org/10.1186/s13045-021-01159-2
Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D (2020) Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia. Leukemia 34(12):3359–3369. https://doi.org/10.1038/s41375-020-0933-7
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399–424
Brodsky RA, Jones RJ (2005) Aplastic anaemia. Lancet 365(9471):1647–1656
Abdelbary H, Magdy R, Moussa M, Abdelmoaty I (2020) Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience. J Egypt Natl Canc Inst 32(1):11. https://doi.org/10.1186/s43046-020-0020-1
Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom AI (2011) Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology 258(3):660–671. https://doi.org/10.1148/radiol.10100025
Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L (2008) HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med 40(6):444–455. https://doi.org/10.1080/07853890801908903
Bacigalupo A (2017) How I treat acquired aplastic anemia. Blood 129(11):1428–1436. https://doi.org/10.1182/blood-2016-08-693481
Marsh JCW, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AWW, Yin JAL (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123(5):782–801
Osugi Y, Yagasaki H, Sako M, Kosaka Y, Taga T, Ito T, Yamamoto M, Ohara A, Sato T, Mimaya J, Tsukimoto I, Kojima S (2007) Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 92(12):1687–1690
Wang H, Tu M, Fu R, Wu Y, Liu H, Xing L, Shao Z (2014) The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China. PLoS One 9(5):e98142. https://doi.org/10.1371/journal.pone.0098142
Cesaro S, Pillon M, Sauer M, Smiers F, Faraci M, de Heredia CD, Wynn R, Greil J, Locatelli F, Veys P, Uyttebroeck A, Ljungman P, Chevalier P, Ansari M, Badell I, Güngör T, Salim R, Tischer J, Tecchio C, Russell N, Chybicka A, Styczynski J, Krivan G, Smith O, Stein J, Afanasyev B, Pochon C, Menconi MC, Bosman P, Mauro M, Tridello G, de Latour RP, Dufour C (2020) Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT). Bone Marrow Transplant 55(9):1796–1809. https://doi.org/10.1038/s41409-020-0863-z
Ikawa Y, Nishimura R, Kuroda R, Mase S, Araki R, Maeba H, Wada T, Toma T, Koizumi S, Yachie A (2013) Expansion of a liver-infiltrating cytotoxic T-lymphocyte clone in concert with the development of hepatitis-associated aplastic anaemia. Br J Haematol 161(4):599–602. https://doi.org/10.1111/bjh.12259
Bowen DG, Warren A, Davis T, Hoffmann MW, McCaughan GW, de St F, Groth B, Bertolino P (2002) Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology 123(4):1252–1264
Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL (1987) Hepatitis-associated aplastic anemia after liver transplantation. Transplantation 43(4):595–597
Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ, Sorrell MF, Shaw BW (1994) Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 20(4 Pt 1):813–818
Delehaye F, Habes D, Dourthe M-E, Bertrand Y, Michel G, Gaudichon J, Debray D, Nelken B, Pasquet M, Blanche S, Leblanc T (2020) Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey. Pediatr Blood Cancer 67(4):e28177. https://doi.org/10.1002/pbc.28177
Itterbeek P, Vandenberghe P, Nevens F, Fevery J, Aerts R, Yap SH, Demuynck H, Fourneau I, Koshiba T, Emonds M-P, Roskams T, Boogaerts M, Pirenne J (2002) Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int 15(2–3):117–123
Acknowledgements
We extend our gratitude to all colleagues who contributed to this paper.
Funding
This work was supported by the National Natural Science Foundation of China (82100227), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), and the Key Program of National Natural Science Foundation of China (81930004).
Author information
Authors and Affiliations
Contributions
Prof. L. P Xu and Prof. X. J Huang designed the study. X.D. Ma and Y.Y. Zuo collected and analyzed the data. All authors reviewed and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xiaodi Ma and Yangyang Zuo contributed equally to this work and share first authorship.
Rights and permissions
About this article
Cite this article
Ma, X., Zuo, Y., Xu, Z. et al. Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia. Ann Hematol 101, 1815–1823 (2022). https://doi.org/10.1007/s00277-022-04885-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-04885-w